Rowley Law PLLC is investigating potential securities law violations by Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) and its board of directors concerning the proposed acquisition of the company by MEI Pharma, Inc. (NASDAQ: MEIP). Infinity Pharmaceutical stockholders are expected to own 42% of the combined company. The all-stock transaction is expected to close in mid-2023.

If you are a stockholder of Infinity Pharmaceuticals, Inc. and are interested in obtaining additional information regarding this investigation, please fill in the contact form on this page. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [email protected], or by telephone at 914-400-1920 or 844-400-4643 (toll-free).

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Request Information

    The submission of this form does not create an attorney-client relationship.